Regulus Therapeutics
RGLS
#8761
Rank
A$0.15 B
Marketcap
$2.39
Share price
10.64%
Change (1 day)
12.72%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$9.1 Million

According to Regulus Therapeutics's latest financial reports the company's total liabilities are A$9.1 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$19.72 M5.98%
2021-12-31A$18.61 M23.63%
2020-12-31A$15.05 M-52.22%
2019-12-31A$31.51 M-34.27%
2018-12-31A$47.95 M-12.11%
2017-12-31A$54.55 M-11.8%
2016-12-31A$61.85 M164.98%
2015-12-31A$23.34 M-51.59%
2014-12-31A$48.22 M45.28%
2013-12-31A$33.19 M-16.73%
2012-12-31A$39.86 M-51.56%
2011-12-31A$82.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$91.47 B 1,005,022.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$93.25 B 1,024,549.71%๐Ÿ‡ซ๐Ÿ‡ท France
A$18.32 B 201,218.63%๐Ÿ‡บ๐Ÿ‡ธ USA
A$99.22 B 1,090,199.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$6.39 B 70,170.97%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.10 B 1,067.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$117.19 B 1,287,707.34%๐Ÿ‡บ๐Ÿ‡ธ USA